Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed indications include h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Pancreatic Adenocarcinoma
• Urothelial Carcinoma

Drugs mentioned

• DECOY20
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Indaptus Therapeutics, Inc | Conditions: Solid Tumor, Adult, HCC - Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING